/Companies

WittGen

2 known investors

Find your way into WittGen

Sign up to see every warm intro you have to WittGen

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the WittGen team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Wittgen Bio applies single-cell generative AI to reconstruct cellular-level profiles from bulk RNA or image samples, producing virtual patient profiling for patient stratification. It targets clinical trial teams in oncology, aiming to de-risk trials by identifying responder populations and extracting biomarkers from existing samples.

Founders & leadership

YR
Yun RhieFounder
MJ
Minwoo JungFounder

Investors · 2

Frequently asked questions

What does WittGen do?
Wittgen Bio applies single-cell generative AI to reconstruct cellular-level profiles from bulk RNA or image samples, producing virtual patient profiling for patient stratification. It targets clinical trial teams in oncology, aiming to de-risk trials by identifying responder populations and extracting biomarkers from existing samples.
Who founded WittGen?
WittGen was founded by Yun Rhie, Minwoo Jung.
Who are WittGen's investors?
WittGen's investors include PharmStars Ventures, Plug and Play Ventures.